EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition

• Published in: Cellular signalling Vol. 47; pp. 122 - 130
• Main Authors: Kim, Song Hee, Lee, Won Hyeok, Kim, Seong Who, Je, Hyoung Uk, Lee, Jong Cheol, Chang, Hyo Won, Kim, Young Min, Kim, Kyungbin, Kim, Sang Yoon, Han, Myung Woul
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01-07-2018
• Subjects: EphA3; Epithelial-mesenchymal transition; Head and neck cancer; Radioresistance; Radiosensitivity; Epithelial-mesenchymal transition; Head and neck cancer; Radioresistance; Radiosensitivity; EphA3
• ISSN: 0898-6568; 1873-3913
• DOI: 10.1016/j.cellsig.2018.04.001

Radiotherapy is a well-established therapeutic modality used in the treatment of many cancers. However, radioresistance remains a serious obstacle to successful treatment. Radioresistance can cause local recurrence and distant metastases in some patients after radiation treatment. Thus, many studies have attempted to identify effective radiosensitizers. Eph receptor functions contribute to tumor development, modulating cell-cell adhesion, invasion, neo-angiogenesis, tumor growth and metastasis. However, the role of EphA3 in radioresistance remains unclear. In the current study, we established a stable radioresistant head and neck cancer cell line (AMC HN3R cell line) and found that EphA3 was expressed predominantly in the radioresistant head and neck cancer cell line through DNA microarray, real time PCR and Western blotting. Additionally, we found that EphA3 was overexpressed in recurrent laryngeal cancer specimens after radiation therapy. EphA3 mediated the tumor invasiveness and migration in radioresistant head and neck cancer cell lines and epithelial mesenchymal transition- related protein expression. Inhibition of EphA3 enhanced radiosensitivity in the AMC HN 3R cell line in vitro and in vivo study. In conclusion, our results suggest that EphA3 is overexpressed in radioresistant head and neck cancer and plays a crucial role in the development of radioresistance in head and neck cancers by regulating the epithelial mesenchymal transition pathway.
•EphA3 is expressed highly in radioresistant head and neck cancer.•EphA3 mediates tumor invasiveness and migration in radioresistant head and neck cancer cell lines.•EphA3 can regulate radioresistance through EMT.